Catherine Hallam

463 total citations
20 papers, 380 citations indexed

About

Catherine Hallam is a scholar working on Molecular Biology, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Catherine Hallam has authored 20 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Physiology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Catherine Hallam's work include Asthma and respiratory diseases (3 papers), Neonatal Health and Biochemistry (2 papers) and Drug Solubulity and Delivery Systems (2 papers). Catherine Hallam is often cited by papers focused on Asthma and respiratory diseases (3 papers), Neonatal Health and Biochemistry (2 papers) and Drug Solubulity and Delivery Systems (2 papers). Catherine Hallam collaborates with scholars based in United Kingdom and United States. Catherine Hallam's co-authors include Clive G. Jackson, Stephen Connolly, David Robinson, Nigel P. Gensmantel, A.V. Wallace, Gene C. Palmer, Edward Wells, Richard D. Carr, Susan Currie and Godfrey L. Smith and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

Catherine Hallam

20 papers receiving 361 citations

Peers

Catherine Hallam
Catherine Hallam
Citations per year, relative to Catherine Hallam Catherine Hallam (= 1×) peers Makiko Nojiri

Countries citing papers authored by Catherine Hallam

Since Specialization
Citations

This map shows the geographic impact of Catherine Hallam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Hallam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Hallam more than expected).

Fields of papers citing papers by Catherine Hallam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Hallam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Hallam. The network helps show where Catherine Hallam may publish in the future.

Co-authorship network of co-authors of Catherine Hallam

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Hallam. A scholar is included among the top collaborators of Catherine Hallam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Hallam. Catherine Hallam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hallam, Catherine, et al.. (2019). Increasing tensile strength by reducing particle size for extrudate-based tablet formulations. Journal of Drug Delivery Science and Technology. 52. 825–830. 4 indexed citations
2.
Sabri, Akmal Hidayat Bin, et al.. (2018). Understanding tablet defects in commercial manufacture and transfer. Journal of Drug Delivery Science and Technology. 46. 1–6. 27 indexed citations
3.
Connolly, Stephen, Catherine Hallam, Clive G. Jackson, et al.. (2002). Design and Synthesis of a Novel and Potent Series of Inhibitors of Cytosolic Phospholipase A2 Based on a 1,3-Disubstituted Propan-2-one Skeleton. Journal of Medicinal Chemistry. 45(6). 1348–1362. 74 indexed citations
4.
Bonnert, Roger V., Roger C. Brown, David A. Chapman, et al.. (1998). Dual D2-Receptor and β2-Adrenoceptor Agonists for the Treatment of Airway Diseases. 1. Discovery and Biological Evaluation of Some 7-(2-Aminoethyl)- 4-hydroxybenzothiazol-2(3H)-one Analogues. Journal of Medicinal Chemistry. 41(25). 4915–4917. 39 indexed citations
5.
Beaton, Haydn G., Stephen Connolly, Anthony R. Cook, et al.. (1994). Discovery of new non-phospholipid inhibitors of the secretory phospholipases A2. Journal of Medicinal Chemistry. 37(5). 557–559. 40 indexed citations
6.
Palmer, Gene C., et al.. (1992). Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze. Neuroreport. 3(10). 922–924. 42 indexed citations
7.
Connolly, Stephen, Nigel P. Gensmantel, Catherine Hallam, et al.. (1992). Design and synthesis of some substrate analog inhibitors of phospholipase A2 and investigations by NMR and molecular modeling into the binding interactions in the enzyme-inhibitor complex. Journal of Medicinal Chemistry. 35(16). 2939–2951. 44 indexed citations
8.
Baxter, Andrew, et al.. (1992). (R)-2-(3-mercapto-2(S)-methyl-1-oxopropoxy)-3-(methylthio)propanoic acid (FPL 66564), the first ultra-short-acting angiotensin converting enzyme inhibitor. Journal of Medicinal Chemistry. 35(20). 3718–3720. 4 indexed citations
9.
Currie, Susan, et al.. (1992). Bombesin stimulates the rapid activation of phospholipase A2-catalyzed phosphatidylcholine hydrolysis in Swiss 3T3 cells.. Journal of Biological Chemistry. 267(9). 6056–6062. 27 indexed citations
10.
Blackham, A., R. Griffiths, Catherine Hallam, et al.. (1990). FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor. Inflammation Research. 30(3-4). 432–442. 10 indexed citations
11.
Campbell, Alison, S.T. Harper, Catherine Hallam, et al.. (1989). Enhancement of leukotriene C4 release from primate airway macrophages by cellular interactions. British Journal of Pharmacology. 98(2). 637–645. 19 indexed citations
12.
Wilkinson, David J., et al.. (1985). Rapid analysis of lipoxygenase products of arachidonic acid by high-performance liquid chromatography. Biochemical Society Transactions. 13(6). 1230–1231. 3 indexed citations
13.
Wilkinson, David J., et al.. (1985). 15-l(S)-Hydroxy-5z, 8z, 11z, 13e-eicosatetraenoic acid is a substrate for 5-lipoxygenase. Biochemical Society Transactions. 13(1). 180–182. 4 indexed citations
14.
Hallam, Catherine, et al.. (1984). Inhibition of platelet 12-lipoxygenase by hydroxy-fatty acids. Biochemical Society Transactions. 12(5). 839–841. 10 indexed citations
15.
Hallam, Catherine, et al.. (1982). Rat eosinophil-mediated antibody-dependent cellular cytotoxicity: investigations of the mechanisms of target cell lysis and inhibition by glucocorticoids.. PubMed. 48(3). 641–8. 17 indexed citations
16.
Hallam, Catherine & R. Whittam. (1977). The role of sodium ions in ATP formation by the sodium pump. Proceedings of the Royal Society of London. Series B, Biological sciences. 198(1131). 109–128. 3 indexed citations
17.
Whittam, R., et al.. (1976). Observations on ouabain binding and membrane phosphorylation by the sodium pump. Proceedings of the Royal Society of London. Series B, Biological sciences. 193(1112). 217–234. 4 indexed citations
18.
Hallam, Catherine & John M. Wrigglesworth. (1976). Hydrogen-ion titration studies on erythrocyte membranes. Biochemical Journal. 156(1). 159–165. 6 indexed citations
19.
Hallam, Catherine & R. Whittam. (1975). Proceedings: The stimulation by phosphate of ouabain binding to the soduim pump and its dependence on the method of preparing the membranes.. PubMed. 252(2). 84P–85P. 1 indexed citations
20.
Hallam, Catherine & John M. Wrigglesworth. (1973). Calcium Ion-Induced Modifications of Charged Groups in Erythrocyte Membranes. Biochemical Society Transactions. 1(2). 440–442. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026